Multiple electrode vectors for implantable cardiac treatment devices

Patent metadata

Field	Value
Publication number	US-9764152-B2
Application number	US-201615138674-A
Country	US
Kind code	B2
Filing date	Apr 26, 2016
Priority date	Jul 28, 2003
Publication date	Sep 19, 2017
Grant date	Sep 19, 2017

Abstract

The implantable cardiac treatment system of the present invention is capable of choosing the most appropriate electrode vector to sense within a particular patient. In certain embodiments, the implantable cardiac treatment system determines the most appropriate electrode vector for continuous sensing based on which electrode vector results in the greatest signal amplitude, or some other useful metric such as signal-to-noise ratio (SNR). The electrode vector possessing the highest quality as measured using the metric is then set as the default electrode vector for sensing. Additionally, in certain embodiments of the present invention, a next alternative electrode vector is selected based on being generally orthogonal to the default electrode vector. In yet other embodiments of the present invention, the next alternative electrode vector is selected based on possessing the next highest quality metric after the default electrode vector. In some embodiments, if analysis of the default vector is ambiguous, the next alternative electrode vector is analyzed to reduce ambiguity.

First claim

What is claimed is:

1. An implantable medical device comprising operational circuitry configured to receive cardiac electrical signals from at least first, second and third implantable electrodes such that at least first and second sensing vectors for sensing cardiac electrical signals are available to the operational circuitry, wherein the operational circuitry is configured to analyze cardiac activity in order to identify an arrhythmia as follows:
receiving signals from each of the first and second sensing vectors including capturing a representation of a cardiac signal in each of the first and second vectors;
analyzing the representation of the cardiac signal captured from the first sensing vector to generate a first result;
determining whether the first result unambiguously indicates a non-malignant cardiac rhythm and:
if the first result does not unambiguously indicate a non-malignant cardiac rhythm, analyzing the representation of the cardiac signal captured using the second vector;
if the first result unambiguously indicates a non-malignant cardiac rhythm, foregoing analysis of the representation of the cardiac signal captured using the second vector.

2. The device of claim 1 wherein the operational circuitry is configured such that the first result is generated from a measure of variability of correlation between representations of the cardiac signal captured from the first vector and a stored template.

3. The device of claim 2 wherein the operational circuitry is configured such that the non-malignant cardiac rhythm is one of atrial tachycardia or sinus tachycardia.

4. The device of claim 1 wherein the operational circuitry is configured such that the first result is generated from a measure of variability of correlation between representations of the cardiac captured from the first vector and a template acquired after a triggering event.

5. The device of claim 4 wherein the operational circuitry is configured such that the triggering event is the identification of a rate between 170 and 260 beats per minute.

6. The device of claim 4 wherein the operational circuitry is configured such that the non-malignant cardiac rhythm is one of atrial tachycardia or sinus tachycardia.

7. The device of claim 1 wherein the operational circuitry is configured such that the first result is generated from observation that no rate acceleration event has taken place, and wherein the non-malignant cardiac rhythm is sinus tachycardia.

8. The device of claim 1 wherein the operational circuitry is housed in a canister along with a battery and high voltage circuitry for delivery of electrical defibrillation or cardioversion therapy, the canister being adapted to receive a lead having a plurality of electrodes thereon, such that the first, second and third electrodes comprise at least one electrode on the canister and at least one electrode on a lead.

9. The device of claim 8 wherein the operational circuitry is configured to deliver defibrillation therapy in response to identification of a malignant arrhythmia, and to withhold defibrillation therapy if a non-malignant cardiac rhythm is identified.

10. An implantable medical device system comprising the device of claim 8 and an implantable lead having a plurality of electrodes thereon.

11. An implantable medical device comprising operational circuitry configured to receive cardiac electrical signals from at least first, second and third implantable electrodes such that at least first and second sensing vectors for sensing cardiac electrical signals are available to the operational circuitry, wherein the operational circuitry is configured to analyze cardiac activity in order to identify an arrhythmia as follows:
receiving signals from each of the first and second sensing vectors including capturing a representation of a cardiac signal in each of the first and second vectors;
analyzing the representation of the cardiac signal captured from the first sensing vector to generate a first result;
determining whether the first result unambiguously indicates the presence of a malignant arrhythmia and:
if the first result does not unambiguously indicate the presence of a malignant cardiac rhythm, analyzing the representation of the cardiac signal captured using the second vector;
if the first result unambiguously indicates the presence of a malignant cardiac rhythm, foregoing analysis of the representation of the cardiac signal captured using the second vector and concluding that the cardiac signal captured by the representation in each of the first and second vectors indicates an arrhythmia.

12. The implantable medical device of claim 11 wherein the operational circuitry is configured such that the first result is generated by comparing the representation of the cardiac signal captured from the first sensing vector to a stored template of sinus rhythm, and if the first result indicates low correlation it is found to unambiguously indicate the presence of a malignant cardiac rhythm that is one of polymorphic ventricular tachycardia, or ventricular fibrillation.

13. The implantable medical device of claim 11 wherein the operational circuitry is configured such that the first result is generated from a measure of variability of correlation between sensed representations along the first vector and a stored template, and if the first result indicates low variability it is found to unambiguously indicate the presence of a malignant cardiac rhythm that is monomorphic ventricular tachycardia.

14. The implantable medical device of claim 11 wherein the operational circuitry is configured such that the first result is generated by comparing the representation of the cardiac signal captured from the first sensing vector to a template of cardiac signal captured after a triggering event in which the rate is in the range of 180 to 260 beats per minute, and if the first result indicates low correlation it is found to unambiguously indicate the presence of a malignant cardiac rhythm that is one of polymorphic ventricular tachycardia, or ventricular fibrillation.

15. The implantable medical device of claim 11 wherein the operational circuitry is configured such that the first result is generated from a measure of variability of correlation between representations of the cardiac signal from first vector and a template of cardiac signal captured after a triggering event in which the rate is in the range of 180 to 260 beats per minute, and if the first result indicates low variability it is found to unambiguously indicate the presence of a malignant cardiac rhythm that is monomorphic ventricular tachycardia.

16. The implantable medical device of claim 11 wherein the operational circuitry is configured such that the first result is generated from a measure of interval rate stability, and if the first result indicates that the interval rate stability is outside of plus/minus 30 milliseconds, the first result is found to unambiguously indicate the presence of a malignant cardiac rhythm that is one of polymorphic ventricular tachycardia, or ventricular fibrillation.

17. The device of claim 11 wherein the operational circuitry is housed in a canister along with a battery and high voltage circuitry for delivery of electrical defibrillation or cardioversion therapy, the canister being adapted to receive a lead having a plurality of electrodes thereon, such that the first, second and third electrodes comprise at least one electrode on the canister and at least one electrode on a lead.

18. The device of claim 17 wherein the operational circuitry is

Assignees

• Cameron Health Inc
• Cameron Health Inc

Inventors

• Warren Jay A
• Bardy Gust H

Classifications

• A61B5/04011

  Human Necessities · mapped topic

• A61B5/7207

  of noise induced by motion artifacts · CPC title

• A61B5/042

  Human Necessities · mapped topic

• A61B5/7203

  for noise prevention, reduction or removal · CPC title

• A61B5/0424

  Human Necessities · mapped topic